The United Nations agency World Health Organization (WHO) on Friday approved Johnson & Johnson covid-19 vaccine to be used for emergency purposes.
In what is seen as a broadening access to the covid-19 jabs, it is the third vaccination that has been given a go ahead by the WHO after those of AstraZeneca and Pfizer/BioNTech that have been used in many countries to contain the coronavirus pandemic.
The approval and listing implies that Johnson & Johnson vaccine can be used in the whole world and for the vaccine platform COVAX’s roll-out. This announcement comes in the wake of Thursday’s authorization by the European Medicines Agency (EMA).
- US City To Dim Lights To Protect Birds From Crashing And Dying
- Pevert Ladies Who Fought For Eric Omondi Arrested
- Amason Kingi Dumps Raila, Says He Is Tired Of Being A Squatter In ODM
“Every new, safe and effective tool against COVID-19 is another step closer to controlling the pandemic,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement
“But the hope offered by these tools will not materialize unless they are made available to all people in all countries.”
RELATED STORY: Denmark Suspends Use Of Astrazeneca Vaccine Over Blood Clot